EU High Court Glaxo Ruling Validates Pay-For-Delay Fines
The European Court of Justice handed down important guidance Thursday clarifying the circumstances under which pay-for-delay deals between brand and generic drug makers staving off generic competition can violate European Union...To view the full article, register now.
Already a subscriber? Click here to view full article